The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (Ciberdem) is a public state consortium established by the Carlos III Health Institute (Ministry of Economy and Competitiveness). Constituted by 31 elite research groups in 19 associate institutions, it represents the biggest network of scientific diabetes research in Spain. Its objectives are to lead highest standards of research practice and to accelerate the translation of scientific results into clinical application.
Ciberdem looks to involve not only the scientific community but also the business sector in R&D investment. The consortium offers companies the possibility of working together on research projects, scientific consultancy, organisation of scientific events and socially responsible corporate actions.
Ciberdem divulges its scientific work through multiple actions such as the periodic organisation of scientific seminars and its annual Science Open Day always with the active collaboration of patient associations.
In its mision to promote diabetes research Ciberdem has created «Investiga la diabetes», an initiative which seeks to increase awareness of the diabetes problem in Spain. Its objective is to generate active participation from society and business with the aim of collecting funds which will enable the continued promotion and financing of scientific activity to find new means of preventing, diagnosing, treating and curing diabetes.
ciberdem.org
investigaladiabetes.org
Specialties
Diabetes, Metabolic Disorders, Biomedicine, Research, Science
CIBERDEM Activity on LinkedIn
-
CIBERDEM Oferta de contrato predoctoral IIB-CSIC. Se busca un candidato para realizar la tesis doctoral con financiación obtenida de una ayuda a grupos de investigación de la CAM en Biomedicina. -
CIBERDEM Descubren una molécula clave para detectar y tratar el dolor crónico. El investigador Oscar Yanes es uno de los autores de esta investigación iniciada en el Scripps Research Institute en San Diego (EEUU). Ahora, sigue el trabajo desde la Universitat Rovira i Virgili y Ciberdem (Biocat, 21/02/2012)
-
CIBERDEM Beca FPI para el proyecto Bisphenol-A effects on glucose homeostasis, islet function and insulin signaling in mice. Deadline: 10/02/2012.
-
CIBERDEM Follow us on twitter.com/ciberdem.
-
CIBERDEM Entrevista al Dr. Ramon Gomis e Ingrid Ramon, coordinador y adiestradora respectivamente del Proyecto Amicus Canis de Ciberdem. Por Sonia Urbano (España Directo, RNE, 24/01/2012)
-
CIBERDEM Job offer in GABRMN: FPI PhD Fellowship at the Grup d'Aplicacions Biomèdiques de la RMN associated to project SAF2011-23870.
-
CIBERDEM Entrevista al Dr. Enric Esmatjes, coordinador del Estudio Telemed-diabetes. Este estudio, impulsado por Ciberdem, estudia el coste y la eficacia de la atención a través de la telemedicina. Se trata de averiguar qué beneficios puede tener en términos económicos y clínicos. Por Manel Torrejón (Diabetesfede, nº17)
-
CIBERDEM Oferta de empleo en Cabimer: La Fundación Progreso y Salud, dependiente de la Consejería de Salud de la Junta de Andalucía, precisa incorporar para el Centro Andaluz de Biología Molecular y Medicina Regenerativa (Cabimer) un/a profesional para el grupo de investigación liderado por el Dr. Bernat Soria que se adscribe a la Red de Terapia Celular del Instituto de Salud Carlos III. Deadline: 19/01/2012.
